|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 548.12 USD | +0.61% |
|
-7.48% | +64.98% |
| 12-03 | Medpace Holdings Insider Sold Shares Worth $17,114,847, According to a Recent SEC Filing | MT |
| 12-01 | Medpace Holdings Insider Sold Shares Worth $34,074,470, According to a Recent SEC Filing | MT |
| Capitalization | 15.44B 13.27B 12.43B 11.59B 21.4B 1,390B 23.28B 145B 56.15B 656B 57.95B 56.71B 2,400B | P/E ratio 2025 * |
37x | P/E ratio 2026 * | 33.2x |
|---|---|---|---|---|---|
| Enterprise value | 15.03B 12.92B 12.1B 11.28B 20.84B 1,353B 22.66B 142B 54.66B 639B 56.41B 55.21B 2,336B | EV / Sales 2025 * |
5.99x | EV / Sales 2026 * | 5.11x |
| Free-Float |
83.69% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Medpace Holdings, Inc.
| 1 day | +0.61% | ||
| 1 week | -7.48% | ||
| Current month | -7.48% | ||
| 1 month | -7.44% | ||
| 3 months | +12.55% | ||
| 6 months | +84.86% | ||
| Current year | +64.98% |
| 1 week | 530.96 |  | 596.51 |
| 1 month | 530.96 | | 626.26 |
| Current year | 250.05 | | 626.26 |
| 1 year | 250.05 | | 626.26 |
| 3 years | 167 | | 626.26 |
| 5 years | 126.94 | | 626.26 |
| 10 years | 21.76 | | 626.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
August Troendle
CEO | Chief Executive Officer | 68 | 30/06/1992 |
Kevin Brady
DFI | Director of Finance/CFO | 50 | 31/07/2021 |
Jesse Geiger
PSD | President | 50 | 31/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
August Troendle
CHM | Chairman | 68 | 30/06/1992 |
Robert Kraft
BRD | Director/Board Member | 54 | 30/06/2016 |
Brian Carley
BRD | Director/Board Member | 71 | 30/06/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.61% | -7.48% | +56.37% | +169.06% | 15.44B | |
| -0.95% | -1.24% | +4.02% | +12.98% | 47.37B | |
| +0.41% | -1.81% | +11.46% | +7.61% | 38.46B | |
| -2.56% | -5.20% | +57.04% | +72.14% | 35.73B | |
| +0.38% | -1.24% | +11.14% | +21.03% | 27.23B | |
| +1.48% | +2.42% | +65.68% | +225.06% | 15.4B | |
| +0.05% | +0.47% | -14.53% | -7.21% | 14.19B | |
| +0.43% | -1.63% | +51.98% | - | 13.64B | |
| -0.16% | -1.27% | +114.33% | +114.78% | 13.23B | |
| -1.51% | -3.24% | +54.47% | +70.26% | 12.55B | |
| Average | -0.18% | -2.03% | +41.19% | +76.19% | 23.32B | |
| Weighted average by Cap. | -0.40% | -2.15% | +32.38% | +56.61% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.51B 2.16B 2.02B 1.88B 3.48B 226B 3.79B 23.65B 9.13B 107B 9.42B 9.22B 390B | 2.81B 2.42B 2.26B 2.11B 3.9B 253B 4.24B 26.48B 10.23B 120B 10.55B 10.33B 437B |
| Net income | 436M 375M 351M 327M 605M 39.27B 658M 4.11B 1.59B 18.54B 1.64B 1.6B 67.81B | 480M 412M 386M 360M 665M 43.17B 723M 4.52B 1.74B 20.39B 1.8B 1.76B 74.55B |
| Net Debt | -409M -352M -329M -307M -567M -36.81B -617M -3.85B -1.49B -17.39B -1.54B -1.5B -63.57B | -1.07B -916M -858M -800M -1.48B -95.92B -1.61B -10.04B -3.88B -45.3B -4B -3.91B -166B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/25 | 548.12 $ | +0.61% | 353,545 |
| 04/12/25 | 544.77 $ | -5.50% | 580,094 |
| 03/12/25 | 576.49 $ | -1.24% | 245,168 |
| 02/12/25 | 583.70 $ | -0.73% | 327,491 |
| 01/12/25 | 587.98 $ | -0.76% | 284,505 |
Delayed Quote Nasdaq, December 05, 2025 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MEDP Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition